SBRT may ease toxicity, but the lower doses could come at the expense of cancer control, new data indicate. Experts suggest a ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...

Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...

For patients with intermediate-risk localized prostate cancer, stereotactic body radiation therapy (SBRT) yields favorable bowel health-related quality of life (HRQOL).

Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...

A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.

The phase 3 NRG Oncology GU005 trial tested SBRT vs MH-IMRT radiation for intermediate-risk prostate cancer for disease control and quality of life.

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...